Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Dura signs collaboration agreements for Spiros inhalation system

June 4, 1997

Trega Biosciences and Chiroscience collaborate on cell adhesion inhibitors

June 4, 1997

NIH sponsors Kosan Biosciences' research in immunology and CNS diseases

June 3, 1997

Xenova and Warner-Lambert enter further drug discovery collaboration

June 2, 1997

Integrin recognition surface identified

May 29, 1997

PharmaSciences and BTG extend license for hydrogel drug delivery technology

May 27, 1997

Scriptgen and Lilly enter drug discovery collaboration

May 23, 1997

RPR and Stanford enter research agreement for drug discovery and gene therapy

May 23, 1997

DepoMed seeks alliances for drug delivery systems

May 21, 1997

HemaSure stops development of SteriPath

May 20, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...